Clinical updates, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Alimera, Anavex, Apnimed, Atara, Biogen, BMS, Brainstorm, Crispr, EMD, Eyepoint, Faraday, First Wave, Genentech, Horizon, I-Mab, Immune-Onc, Immunitybio, Neoimmunetech, Neurobo, Oncolytics, Oryzon, Outlook, Resverlogix, Rhizen, Sanofi, Smart Immune, TC, Tizona, Ultimovacs, Union, VBI, Veru, Vistagen.